For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Join Valeria Busygina as she presents our recent poster on commercial antibody development from the 2019 Bristol-Myers Squibb R&D Symposium.
Using case studies, gain insight into our antibody discovery capabilities from research to diagnostic and therapeutic development bringing:
About the Presenter:
Valeria joined Abcam in November 2015, upon the acquisition of AxioMx, where she had worked building their phage display capabilities since February 2012. Valeria is a member of the CSD Global Leadership Team and, since February 2018, leads the operational USA Custom Solutions teams in both Branford, CT and Burlingame, CA. With expertise in genetics, molecular biology and protein sciences, in addition to her knowledge of multiple antibody discovery platforms, Valeria spearheads the development of our Next Generation Sequencing and antibody engineering capabilities. Valeria received her Ph.D. degree in Genetics from Yale University and completed her postdoctoral training in protein biochemistry and enzymology also at Yale. She is an author of 15 peer-reviewed publications.